CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) - USD ($) |
12 Months Ended | |
|---|---|---|
Oct. 31, 2017 |
Oct. 31, 2016 |
|
| Research and Development Expense [Member] | ||
| Non-cash Stock option compensation expenses | $ 288,187 | $ 259,930 |
| Selling and Marketing Expense [Member] | ||
| Non-cash Stock option compensation expenses | $ 934,585 | $ 613,631 |
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|